| http://www.w3.org/ns/prov#value | - In addition to our work in PAH, we are researching and developing S1P1 receptor agonists as potential oral treatments for a number of conditions related to autoimmune diseases, including multiple sclerosis, psoriasis, and rheumatoid arthritis.
|
